Have you submitted your comments to the Trump administration regarding the Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses rule? If not, do it today before time runs out!
This rule would have a significant effect on independent pharmacy, in part by ending retroactive DIR fees. APCI has created a sample comment you can submit, or you can send your own. Specifically, these comments urge the administration to:
•Finalize the proposed changes to the negotiated price definition that seeks to include all pharmacy DIR at the point of sale. This change would effectively eliminate retroactive pharmacy DIR, a change that will lower out-of-pocket spending for Medicare patients.
•Develop or approve a standard set of performance metrics on which plans and pharmacies base their contractual agreements, and to finalize proposed changes that exclude from negotiated price contingent amounts that are positive incentive payments made to pharmacies
•Implement safeguards that would provide for reasonable reimbursement to pharmacies participating in Medicare Part D.
•Ensure these changes are effective for plan year 2020
The deadline for submitting comments is January 25, 2019, but don’t wait – COMMENT NOW!
As always, thanks in advance for your help in this effort.
Highlight link below and right click to go to Site